Science Current Events | Science News | Brightsurf.com
 

Cholinesterase inhibitors reduce aggression, wandering and paranoia in Alzheimer's disease

December 10, 2008

INDIANAPOLIS - Cholinesterase inhibitors, used to treat cognitive symptoms of Alzheimer's disease, are also a safe and effective alternative therapy for the behavioral and psychological symptoms of dementia, according to a study that appears in the December 2008 edition of Clinical Interventions in Aging.

Investigators from the Indiana University School of Medicine, the Regenstrief Institute and Wishard Health Services reviewed nine randomized, double-blind, placebo-controlled clinical trials evaluating the effectiveness of three popular cholinesterase inhibitors in managing behavioral and psychological symptoms displayed by patients with Alzheimer's disease.

The researchers report that the trial results indicate cholinesterase inhibitors led to a statistically significant reduction in behavioral and psychological symptoms such as aggression, wandering or paranoia when using the same dosage as administered for improving cognitive impairment.

Nine out of 10 Alzheimer's disease patients display behavioral and psychological symptoms of their disease. The review of the clinical trials revealed that cholinesterase inhibitors are safe, producing no major side effects.

"There is a need for safe alternatives to the anti-psychotic drugs currently used to manage the behavioral and psychological symptoms of Alzheimer's disease. The results of the studies we analyzed are encouraging and suggestive that cholinesterase inhibitors are safe and effective alternatives. However, they are underutilized and typically prescribed for less than three months and for less than 10 percent of patients with Alzheimer's disease. Our findings might provide clinicians with useful data to justify the appropriate use of these medications," said Malaz Boustani, M.D., corresponding author of the Clinical Interventions in Aging paper. Dr. Boustani is assistant professor of medicine at the IU School of Medicine, a Regenstrief Institute research scientist, a research investigator with the IU Center for Aging Research, and chief research officer of the Indianapolis Discovery Network for Dementia.

In Alzheimer's disease there is a decrease in acetylcholine, a chemical in the brain that assists memory, thought and judgment. Cholinesterase inhibitors raise acetylcholine levels. Increased concentrations of acetylcholine in the brain leads to increased communication between nerve cells and may improve or stabilize the symptoms of Alzheimer's disease in the early and moderate stages of progression.

Noll Campbell, PharmD, a clinical pharmacy specialist in geriatric psychiatry with Wishard Health Services and corresponding author of the paper, said that, "This class of medications has already been approved by the Food and Drug Administration to manage symptoms of Alzheimer's-type dementia, although their potential benefits on behavioral symptoms are not frequently identified by many prescribers. Clinical trials of cholinesterase inhibitors have shown benefits in several domains of cognitive function as well as behavioral symptoms associated with dementia, and may improve the management of behavioral problems while reducing the use of more harmful medications that are needed to control behaviors."

Dr. Boustani noted that the vast majority of busy primary care physicians, the doctors who see the majority of patients with Alzheimer's disease, are unaware of the details of the studies analyzed in the Clinical Interventions in Aging paper and he hopes that this new paper, which reviewed the studies, will encourage them to prescribe cholinesterase inhibitors, with its benefits for both cognition and behavior symptoms to their Alzheimer's disease patients.

Indiana University


Related Cholinesterase Inhibitors Current Events and Cholinesterase Inhibitors News Articles


Common medications for dementia could cause harmful weight loss
Medications commonly used to treat dementia could result in harmful weight loss, according to UC San Francisco researchers, and clinicians need to account for this risk when prescribing these drugs to older adults, they said.

AGS unveils revised Choosing Wisely list of topics to talk about with older adults
The American Geriatrics Society (AGS) today released updates to several of its recommendations for the ABIM Foundation's Choosing Wisely® campaign, which raises professional and public awareness about treatments and tests to question and discuss because they may lack efficacy or cause potential harm.

Study shows benefit in activities of daily living and savings in caregiver time with vitamin E
Difficulty with activities of daily living often affect Alzheimer's patients, which is estimated to affect as many as 5.1 million Americans.

Turning Alzheimer's fuzzy signals into high definition
Scientists at the Virginia Tech Carilion Research Institute have discovered how the predominant class of Alzheimer's pharmaceuticals might sharpen the brain's performance.

No evidence drugs, vitamins, supplements help prevent cognitive decline in healthy older adults
A review of published research has found no evidence that drugs, herbal products or vitamin supplements help prevent cognitive decline in healthy older adults.

Many Alzheimer's patients get drugs with opposing effects
You wouldn't brake your car while stepping on the gas-or wash down a sleeping pill with espresso. Yet many people taking common Alzheimer's disease medications-cholinesterase inhibitors-are given medications with anticholinergic properties, which oppose their effects.

New gene test discovered for inherited neuromuscular disorder
Newcastle University scientists have identified a new gene which will allow rapid diagnosis and earlier treatment of a debilitating neuromuscular condition.

Alzheimer's drug boosts perceptual learning in healthy adults
Research on a drug commonly prescribed to Alzheimer's disease patients is helping neuroscientists at the University of California, Berkeley, better understand perceptual learning in healthy adults.

New approach to fighting Alzheimer's shows potential in clinical trial
In the early stages of Alzheimer's disease, patients typically suffer a major loss of the brain connections necessary for memory and information processing.

New approach to fighting Alzheimer's shows potential in clinical trial
In the early stages of Alzheimer's disease, patients typically suffer a major loss of the brain connections necessary for memory and information processing. Now, a combination of nutrients that was developed at MIT has shown the potential to improve memory in Alzheimer's patients by stimulating growth of new brain connections.
More Cholinesterase Inhibitors Current Events and Cholinesterase Inhibitors News Articles

Cholinesterases and Cholinesterase Inhibitors: Basic Preclinical and Clinical Aspects

Cholinesterases and Cholinesterase Inhibitors: Basic Preclinical and Clinical Aspects
by Ezio Giacobini (Author)


With the collaboration of the most distinguished scholars in this field Professor Giacobini has put together a publication which will convey present knowledge in the field of molecular biology and genetics, biochemistry, cell biology, pharmacology and toxicology as well of clinical applications (particularly in the field of Alzheimer's disease therapy) of cholinesterase inhibitors. In a concise but precise manner it condenses our present knowledge of these enzymes and their inhibitors and helps those who want to understand them as well as to utilize them for therapeutic purposes.

Cholinesterase Inhibitors for the management of Alzheimer Disease

Cholinesterase Inhibitors for the management of Alzheimer Disease
by Preet Anand (Author)


Chemistry is an expanding field and presently, medicinal chemistry branch has flourished at a tremendous rate due to active research in this area of field. Alzheimer‟s disease (AD) is a progressive, neurodegenerative disorder of the brain among the elderly. It constitutes one of the major health problems in developed countries along with cardiovascular disorders and cancer. The impairment in the cholinergic function which deals with learning, memory, behaviour and emotional responses, is due to rapid hydrolysis of ACh by acetylcholinesterase enzyme (AChE). Thus, AChE inhibition has been documented as a critical target for the effective management of AD by an increase in the availability of ACh in the brain regions. Hence the symptomatic management of patients with AD is based on...

Current Research

Current Research
by Egiacobini (Author)


Book by Egiacobini

Morgan and Mikhail's Clinical Anesthesiology, 5th edition

Morgan and Mikhail's Clinical Anesthesiology, 5th edition
by John Butterworth (Author), David C. Mackey (Author), John Wasnick (Author)


The most user-friendly, clinically relevant overview of the practice of anesthesiologyA Doody's Core Title for 2015!Current, concise, and engagingly written, Morgan & Mikhail’s Clinical Anesthesiology, Fifth Edition is a true essential for all anesthesia students and practitioners. This trusted classic delivers comprehensive coverage of the field’s must-know basic science and clinical topics in a clear, easy-to-understand presentation. Indispensable for coursework, exam review, and as a clinical refresher, this trusted text has been extensively updated to reflect the latest research and developments.Here’s why Clinical Anesthesiology is the best anesthesiology resource:NEW full-color presentationNEW chapters on the most pertinent topics in anesthesiology, including anesthesia...

Saunders Comprehensive Review for the NCLEX-RN Examination

Saunders Comprehensive Review for the NCLEX-RN Examination
by Linda Anne Silvestri PhD RN (Author)


Often called the ‘the best NCLEX® exam review book ever,’ Saunders Comprehensive Review for the NCLEX-RN® Examination provides everything you need to prepare for the NCLEX exam ― complete content review and over 5,100 NCLEX examination-style questions in the book and online. Don't make the mistake of assuming the quality of the questions is the same in all NCLEX exam review books, because only this book includes the kind of questions that consistently test the critical thinking skills necessary to pass today's NCLEX exam. Even better, all answers include detailed rationales to help you learn from your answer choices, as well as test-taking strategies with tips on how to best approach each question. Written by the most trusted name in NCLEX review, Linda Anne Silvestri, and updated...

First Aid for the Usmle Step 1, 2016

First Aid for the Usmle Step 1, 2016
by Tao Le (Author), Vikas Bhushan (Author)


THE “BIBLE” FOR USMLE STEP 1 PREP―AND THE ULTIMATE TOOL FOR ORGANIZING YOUR STUDY!This annually updated review delivers a comprehensive collection of high-yield facts and mnemonics that pinpoint exactly what students need to know to pass the exam. Co-authored by medical students who recently took the boards, it provides a complete framework to help students prepare for the most stressful exam of their careers.1,250+ must-know topics provide a complete framework for your Step 1 preparationTest-taking advice with focus on high-efficiency studyingUpdated in all subject areas based on feedback from thousands of studentsExtensive faculty review process with nationally known USMLE instructors1,000+ color photos and diagrams help you visualize high-yield conceptsExpanded guide to top-rated...

Varcarolis' Foundations of Psychiatric Mental Health Nursing: A Clinical Approach, 7e

Varcarolis' Foundations of Psychiatric Mental Health Nursing: A Clinical Approach, 7e
by Margaret Jordan Halter PhD PMHCNS (Author)


Using a practical clinical perspective, Varcarolis' Foundations of Psychiatric Mental Health Nursing: A Clinical Approach, 7th Edition provides a clear understanding of the often-intimidating subject of psychiatric mental health nursing. Clinical chapters follow the nursing process framework and progress from theory to application, preparing you for practice with real-world examples. New to this edition are the latest DSM-5 guidelines along with coverage of trauma, pediatric mental health, and QSEN competencies. From new lead author Dr. Margaret Jordan Halter, this comprehensive RN psychiatric nursing text is a bestseller!Reader-friendly features reinforce important information and help in applying textbook content to the clinical setting, emphasizing key terms and concepts, key points to...

Medical-Surgical Nursing: Patient-Centered Collaborative Care, Single Volume, 8e

Medical-Surgical Nursing: Patient-Centered Collaborative Care, Single Volume, 8e
by Donna D. Ignatavicius MS RN ANEF (Author), M. Linda Workman PhD RN FAAN (Author)


Using a unique collaborative care approach to adult health nursing, Medical-Surgical Nursing: Patient-Centered Collaborative Care, 8th Edition covers the essential knowledge you need to succeed at the RN level of practice. Easy-to-read content includes evidence-based treatment guidelines, an enhanced focus on QSEN competencies, and an emphasis on developing clinical judgment skills. This edition continues the book’s trendsetting tradition with increased LGBTQ content and a new Care of Transgender Patients chapter. Written by nursing education experts Donna Ignatavicius and M. Linda Workman, this bestselling text also features NCLEX® Exam-style challenge questions to prepare you for success on the NCLEX Exam. Cutting-edge coverage of the latest trends in nursing practice and nursing...

Pharmacology and the Nursing Process, 8e

Pharmacology and the Nursing Process, 8e
by Linda Lane Lilley PhD RN (Author), Shelly Rainforth Collins PharmD (Author), Julie S. Snyder MSN RN-BC (Author)


Let this outstanding pharmacology text help you learn how to administer drugs safely and effectively! Now in its eighth edition, Pharmacology and the Nursing Process continues to deliver the perfect amount of pharmacology, prioritization, and nursing process information to today’s nursing students. Centering on its unique key drug approach, this text focuses only on the drug information you need to safely administer drugs. The text also continues to emphasize the nursing process and prioritization, covering the most essential assessments, nursing diagnoses, interventions, and evaluations you need to practice effectively. New to this edition is even more coverage of QSEN competencies, simpler language, and a wealth of reader-friendly features and innovative learning aids. Along with its...

Nursing2017 Drug Handbook (Nursing Drug Handbook)

Nursing2017 Drug Handbook (Nursing Drug Handbook)
by Lippincott (Author)


THE best-selling drug guide for nurses & other clinicians
…always dependable, always up to date!
 
 
Look for these outstanding features
Completely updated nursing-focused drug monographs featuring over 3,500 generic, brand-name, and combination drugs in an easy A-to-Z format49 brand-new FDA-approved drugs in this edition—with 36 new comprehensive drug monographs, alphabetized and conveniently grouped in a handy “new drugs” sectionOver 6,000 clinical updates—new dosages and indications, Black Box warnings, adverse reactions, nursing considerations, clinical alerts, and patient teaching informationNEW “pregnancy-lactation-reproduction” heading and “dialyzable drug” logo in each drug monographNEW appendices covering Antidiarrheals and OTC drugsSpecial...

© 2016 BrightSurf.com